Is Interferon Gamma Suppression After Cardiac Surgery Caused by a Decreased Interleukin-12 Synthesis?

Annals of Thoracic Surgery

Volumn 82, Issue 1, 2006, Pages 103-109

  Franke, Axel ^a   Lante, Wolfgang ^a   Kurig, Edmond ^a   Zöller, Lothar G ^a   Weinhold, Christian ^a   Markewitz, Andreas ^a  

^a BUNDESWEHRZENTRALKRANKENHAUS KOBLENZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; RECOMBINANT INTERLEUKIN 12; STAPHYLOCOCCUS ENTEROTOXIN B;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HEART SURGERY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL;

CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; DISEASE SUSCEPTIBILITY; DOWN-REGULATION; ENTEROTOXINS; FEMALE; GENES, MHC CLASS II; HLA-DR ANTIGENS; HUMANS; INFECTION; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; LIPOPOLYSACCHARIDES; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RECOMBINANT PROTEINS; SURGICAL PROCEDURES, ELECTIVE;

EID: 33745187787     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.02.042     Document Type: Article

References (34)

1. Oberholzer A., Oberholzer C., and Moldawer L.L. Cytokine signaling-regulation of the immune response in normal and critically ill states. Crit Care Med 28 4 suppl (2000) N3-N12
2. Zedler S., Bone R.C., Baue A.E., von Donnersmarck G.H., and Faist E. T-cell reactivity and its predictive role in immunosuppression after burns. Crit Care Med 27 (1999) 66-72
3. Spolarics Z., Siddiqi M., Siegel J.H., et al. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients. Crit Care Med 31 (2003) 1722-1729
4. Franke A., Lante W., Fackeldey V., et al. Proinflammatory and antiinflammatory cytokines after cardiac operation. different cellular sources at different times. Ann Thorac Surg 74 (2002) 363-370 discussion 370-61
5. Markewitz A., Faist E., Lang S., Hultner L., Weinhold C., and Reichart B. An imbalance in T-helper cell subsets alters immune response after cardiac surgery. Eur J Cardiothorac Surg 10 (1996) 61-67
6. Fink R., Al-Obaidi M., Grewal S., Winter M., and Pepper J. Monocyte activation markers during cardiopulmonary bypass. Perfusion 18 (2003) 83-86
7. Oczenski W., Krenn H., Jilch R., et al. HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery. Intensive Care Med 29 (2003) 1253-1257
8. Allen M.L., Peters M.J., Goldman A., et al. Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit Care Med 30 (2002) 1140-1145
9. Piccotti J.R., Chan S.Y., Li K., Eichwald E.J., and Bishop D.K. Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFN-gamma-producing cells. J Immunol 158 (1997) 643-648
10. Sablotzki A., Friedrich I., Muhling J., et al. The systemic inflammatory response syndrome following cardiac surgery. different expression of proinflammatory cytokines and procalcitonin in patients with and without multiorgan dysfunctions. Perfusion 17 (2002) 103-109
11. Markewitz A., Faist E., Weinhold C., et al. Alterations of cell-mediated immune response following cardiac surgery. Eur J Cardiothorac Surg 7 (1993) 193-199
12. Sbrana S., Parri M.S., De Filippis R., Gianetti J., and Clerico A. Monitoring of monocyte functional state after extracorporeal circulation. a flow cytometry study. Cytometry B Clin Cytom 58 (2004) 17-24
13. Diegeler A., Tarnok A., Rauch T., et al. Changes of leukocyte subsets in coronary artery bypass surgery. cardiopulmonary bypass versus 'off-pump' techniques. Thorac Cardiovasc Surg 46 (1998) 327-332
14. Markewitz A., Lante W., Franke A., Marohl K., Kuhlmann W.D., and Weinhold C. Alterations of cell-mediated immunity following cardiac operations. clinical implications and open questions. Shock 16 suppl 1 (2001) 10-15
15. Schinkel C., Licht K., Zedler S., et al. Interferon-gamma modifies cytokine release in vitro by monocytes from surgical patients. J Trauma 50 (2001) 321-327
16. Ono S., Ueno C., Aosasa S., Tsujimoto H., Seki S., and Mochizuki H. Severe sepsis induces deficient interferon-gamma and interleukin-12 production, but interleukin-12 therapy improves survival in peritonitis. Am J Surg 182 (2001) 491-497
17. Tsiavou A., Degiannis D., Hatziagelaki E., Koniavitou K., and Raptis S. Flow cytometric detection of intracellular IL-12 release. in vitro effect of widely used immunosuppressants. Int Immunopharmacol 2 (2002) 1713-1720
18. Sablotzki A., Dehne M., Welters I., et al. Alterations of the cytokine network in patients undergoing cardiopulmonary bypass. Perfusion 12 (1997) 393-403
19. Sablotzki A., Mann V., Simm A., and Czeslick E. [Changes in the cytokine network through escalating SIRS after heart surgery. ] Anasthesiol Intensivmed Notfallmed Schmerzther 36 (2001) 552-559
20. Mountford A.P., Coulson P.S., Cheever A.W., Sher A., Wilson R.A., and Wynn T.A. Interleukin-12 can directly induce T-helper 1 responses in interferon-gamma (IFN-gamma) receptor-deficient mice, but requires IFN-gamma signalling to downregulate T-helper 2 responses. Immunology 97 (1999) 588-594
21. Goebel A., Kavanagh E., Lyons A., et al. Injury induces deficient interleukin-12 production, but interleukin-12 therapy after injury restores resistance to infection. Ann Surg 231 (2000) 253-261
22. Wysocka M., Robertson S., Riemann H., et al. IL-12 suppression during experimental endotoxin tolerance. dendritic cell loss and macrophage hyporesponsiveness. J Immunol 166 (2001) 7504-7513
23. Sablotzki A., Dehne M.G., Friedrich I., et al. Different expression of cytokines in survivors and non-survivors from MODS following cardiovascular surgery. Eur J Med Res 8 (2003) 71-76
24. Steinhauser M.L., Hogaboam C.M., Lukacs N.W., Strieter R.M., and Kunkel S.L. Multiple roles for IL-12 in a model of acute septic peritonitis. J Immunol 162 (1999) 5437-5443
25. Dorresteijn M.J., Pickkers P., Netea M.G., et al. IFN-gamma is not induced through increased plasma concentrations of interleukin-12/interleukin-18 during human endotoxemia. Eur Cytokine Netw 16 (2005) 191-193
26. Car B.D., Eng V.M., Lipman J.M., and Anderson T.D. The toxicology of interleukin-12. a review. Toxicol Pathol 27 (1999) 58-63
27. Leonard P., and Sur S. Interleukin-12. potential role in asthma therapy. BioDrugs 17 (2003) 1-7
28. Gollob J.A., Mier J.W., and Atkins M.B. Clinical use of systemic IL-12 therapy. Cancer Chemother Biol Response Modif 19 (2001) 353-369
29. Ono S., Ueno C., Seki S., Matsumoto A., and Mochizuki H. Interleukin-12 and -18 induce severe liver injury in mice recovered from peritonitis after sublethal endotoxin challenge. Surgery 134 (2003) 92-100
30. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3 (2003) 133-146
31. Mitsuhashi M., Liu J., Cao S., Shi X., and Ma X. Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas. J Leukoc Biol 76 (2004) 322-332
32. Malmgaard L. Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res 24 (2004) 439-454
33. Barcellini W., Borghi M.O., Sguotti C., et al. Heterogeneity of immune responsiveness in healthy elderly subjects. Clin Immunol Immunopathol 47 (1988) 142-151
34. Ceddia M.A., Price E.A., Kohlmeier C.K., et al. Differential leukocytosis and lymphocyte mitogenic response to acute maximal exercise in the young and old. Med Sci Sports Exerc 31 (1999) 829-836